Skip to Content Facebook Feature Image

The barista is human but an AI agent runs this experimental Swedish cafe

TECH

The barista is human but an AI agent runs this experimental Swedish cafe
TECH

TECH

The barista is human but an AI agent runs this experimental Swedish cafe

2026-05-11 13:17 Last Updated At:14:57

STOCKHOLM (AP) — The coffee might be poured by a human hand, but behind the counter something far less traditional is calling the shots at an experimental cafe in Stockholm.

San Francisco-based startup Andon Labs has put an artificial intelligence agent nicknamed “Mona” in charge at the eponymous Andon Café in the Swedish capital. While human baristas still brew the coffee and serve the orders, the AI agent — powered by Google’s Gemini — oversees almost every other aspect of the business, from hiring staff to managing inventory.

It is not clear how long the experiment will last, but the AI agent appears to be struggling to turn a profit in Stockholm’s competitive coffee trade. The cafe has made more than $5,700 in sales since it opened in mid-April, but less than $5,000 remains from its original budget of $21,000-plus. Much of the cash was spent on one-time setup costs, and the hope is that it eventually levels out and makes money.

Many cafe patrons have found it amusing to visit a business that's run by AI. Customers can pick up a telephone inside the cafe and ask the agent questions.

“It’s nice to see what happens if you push the boundary,” customer Kajsa Norin said. “The drink was good.”

Experts say ethical concerns abound, ranging from technology's role in humankind's future to conducting job interviews and judging employee performance.

Emrah Karakaya, an associate professor of industrial economics at Stockholm’s KTH Royal Institute of Technology, likened the experiment to “opening Pandora’s box" and said putting AI in charge can cause many problems. What might happen, he said, if a customer gets food poisoning? Who’s to blame?

“If you don’t have the required organizational infrastructure around it, and if you overlook these mistakes, it can cause harm to people, to society, to the environment, to business,” Karakaya said. “The question is, do we care about this negative impact?”

Founded in 2023, Andon Labs is an AI safety and research startup that says it focuses on “stress-testing” AI agents in the real world by giving them “real tools and real money.” It has worked with ChatGPT maker OpenAI, Claude’s Anthropic, Google DeepMind and Elon Musk’s xAI, and the startup says it is preparing for a future where “organizations are run autonomously by AI.”

The Swedish cafe is billed as a “controlled experiment” to explore how AI might be deployed going forward.

“AI will be a big part of society in the future, and therefore we want to make this experiment (to) see what ethical questions arise when we have AI that employs other people and runs a business,” said Hanna Petersson, a member of Andon Labs’ technical staff.

The lab previously held pilots that put Anthropic’s Claude AI in charge of a vending machine business and a San Francisco gift store. The vending machine simulation revealed some worrying traits: The AI agent told customers it would issue refunds but never did, and it also intentionally lied to suppliers about competitor pricing to gain leverage.

Mona got to work after it was prompted with some basic instructions, Petersson said. The team told it to try to run the cafe profitably, be friendly and easygoing, and figure out operational details by itself but ask for new tools if needed.

From there it set up contracts for electricity and internet, and secured permits for food handling and outdoor seating. The agent then advertised for staff on LinkedIn and Indeed, and set up commercial accounts with wholesalers for daily bread and bakery orders. It communicates with the baristas via Slack, often messaging them outside of working hours, which is a workplace no-no in Sweden.

Other problems have arisen, particularly related to inventory.

The AI agent has placed orders for 6,000 napkins, four first-aid kits and 3,000 rubber gloves for the tiny cafe — plus canned tomatoes that aren’t used in any dish the cafe serves.

And then there’s the bread. Sometimes the agent orders far too much, while other days it misses bakeries’ daily deadlines, forcing the baristas to strike sandwiches from the menu.

Petersson said the ordering issues are likely due to the AI assistant’s “limited context window.”

“When old memory of ordering stuff is out of the context window, she completely forgets what she has ordered in the past,” Petersson said.

Barista Kajetan Grzelczak said he isn’t worried about being replaced by AI just yet.

“All the workers are pretty much safe,” he said. “The ones who should be worried about their employment are the middle bosses, the people in management.”

A general view of the entrance of the Andon Café at the Vasastan neighborhood in Stockholm, Sweden, Tuesday, May 5, 2026. (AP Photo/James Brooks)

A general view of the entrance of the Andon Café at the Vasastan neighborhood in Stockholm, Sweden, Tuesday, May 5, 2026. (AP Photo/James Brooks)

Barista Kajetan Grzelczak makes a coffee at Andon Café at the Vasastan neighborhood in Stockholm, Sweden, Tuesday, May 5, 2026. (AP Photo/James Brooks)

Barista Kajetan Grzelczak makes a coffee at Andon Café at the Vasastan neighborhood in Stockholm, Sweden, Tuesday, May 5, 2026. (AP Photo/James Brooks)

Hanna Petersson, a member of Andon Labs’ technical staff, uses a telephone handset to speak with Andon Café's AI agent 'Mona' in Stockholm, Sweden, Tuesday, May 5, 2026. (AP Photo/James Brooks)

Hanna Petersson, a member of Andon Labs’ technical staff, uses a telephone handset to speak with Andon Café's AI agent 'Mona' in Stockholm, Sweden, Tuesday, May 5, 2026. (AP Photo/James Brooks)

LITTLETON, Mass.--(BUSINESS WIRE)--May 11, 2026--

Proton therapy is entering the LINAC vault. At ESTRO 2026, Mevion Medical Systems will introduce the MEVION S250-FIT Proton Therapy System to the European radiation oncology community, the first proton therapy system designed for installation in a standard radiation therapy vault.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507172087/en/

Now both U.S. FDA-cleared and CE-marked under Regulation (EU) 2017/745, the S250-FIT creates a new pathway for cancer centers to bring proton therapy into existing LINAC-based treatment environments, aligning advanced proton capability with the infrastructure, workflows, and capital planning of modern radiation oncology.

Stanford Medicine: First S250-FIT Installation

On April 7, 2026, Stanford Medicine unveiled the world’s first S250-FIT installation, developed in collaboration with Leo Cancer Care. The system was fully installed within a standard 110 m² (1,200 sq ft) LINAC vault inside the existing Stanford Medicine Cancer Center in Palo Alto, without constructing a new building.

“With FIT , proton therapy is no longer limited by infrastructure,” said Tina Yu, Ph.D., CEO and President of Mevion Medical Systems. “For the first time, it can be deployed within the same clinical and operational framework as conventional radiotherapy. For European health systems that have long recognized the benefits of proton therapy but faced significant infrastructure and financial barriers, this changes the question from whether to build a separate proton facility to how to integrate proton therapy into the radiotherapy programs they already operate.”

Advanced Capability in a Compact Footprint

The S250-FIT delivers Intensity Modulated Proton Therapy via Mevion's HYPERSCAN® pencil beam scanning with the Adaptive Aperture® proton multi-leaf collimator and is designed to support DirectARC™ proton arc therapy. The system supports advanced image-guided and adaptive workflows and is FLASH research-ready.* The system is paired with Leo Cancer Care’s Marie® Upright Patient Positioning and CT Imaging System, the first commercial upright treatment platform with an integrated diagnostic CT, offering potential benefits in patient comfort and supporting organ motion management during treatment.

Built on Decades of U.S. and European Clinical Experience

The S250-FIT shares its core technology lineage with the MEVION S250i®, in clinical operation at Siteman Cancer Center at Washington University School of Medicine in the U.S. and at ZON-PTC at Maastro Clinic in the Netherlands, giving Mevion more than a decade of combined U.S. and European clinical experience with compact, single-room proton therapy. Mevion has now signed contracts with nine leading institutions globally for the S250-FIT, including Stanford Health Care, Loma Linda University Health, UNC Health, BayCare Health System, Atlantic Health System, and University of Nebraska Medical Center.

Meet Mevion at ESTRO 2026

Visit Mevion at Booth #C08:89 to engage with the Mevion team and discuss site planning, clinical workflows, and integration pathways with our clinical and engineering leadership.

*The FLASH Research Kit is not currently available for commercial sale or for human clinical use.

About Mevion Medical Systems

Mevion Medical Systems is the leading provider of compact proton therapy systems for cancer care. Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion pioneered the single-room platform and continues to further the science and application of proton therapy. Since 2013, Mevion’s compact proton therapy single-room systems have been used by leading cancer centers for treating patients. Mevion’s series of products, including the flagship MEVION S250i and MEVION S250-FIT™ with HYPERSCAN pencil beam scanning, represent the world’s most compact proton therapy systems that eliminate the obstacles of size, complexity, and cost. Mevion is headquartered in Littleton, Massachusetts, with a presence in Europe and Asia. For more information, please visit www.mevion.com.

The MEVION S250-FIT™ Proton Therapy System

The MEVION S250-FIT™ Proton Therapy System

Recommended Articles